Biological agents in the management of adult-onset Still's disease

Joint Bone Spine. 2019 Jan;86(1):5-7. doi: 10.1016/j.jbspin.2018.03.010. Epub 2018 Apr 6.

Authors

Charlotte Girard-Guyonvarc'h¹, Cem Gabay²

Affiliations

¹ Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, 26 Avenue de Beau-Séjour, 1211 Geneva 14, Switzerland.
² Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, 26 Avenue de Beau-Séjour, 1211 Geneva 14, Switzerland. Electronic address: cem.gabay@hcuge.ch.

PMID: 29631071
DOI: 10.1016/j.jbspin.2018.03.010

No abstract available

Keywords: Adult onset Still's disease; Autoinflammatory disease; Biological DMARDs; Cytokines.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Biological Factors / therapeutic use*
Humans
Still's Disease, Adult-Onset / drug therapy
Still's Disease, Adult-Onset / immunology
Still's Disease, Adult-Onset / therapy*

Substances

Antibodies, Monoclonal, Humanized
Biological Factors